Announcements Trials
Browse Landscape

Phase

Phase 2 308Phase 1 160Phase 3 124Phase NA 65Phase 1/2 62Phase 2/3 20Phase EARLY_PHASE1 13Phase 4 4

Status

Completed 3Unknown 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Gastrointestinal 1CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Metastasising Cancer of Unknown Primary 1Mediastinal Neoplasms 1Lymphoma, Large-Cell, Anaplastic 1Glioblastoma 1Esophageal Neoplasms 1Burkitt Lymphoma 1

Interventions

Dexamethasone 56Metformin 50Cyclophosphamide 47Saline Solution 39Cytarabine 37Cisplatin 36Zoledronic Acid 34Letrozole 34Carboplatin 33Sodium Chloride 32Bupivacaine 31Docetaxel 30Bevacizumab 30Vincristine 29Methotrexate 29Fluorouracil 28Propofol 27Capecitabine 27Fentanyl 26Doxorubicin 26Rituximab 25Drug Therapy 25Dexmedetomidine 25Prednisone 23Paclitaxel 23Oxaliplatin 21Morphine 21Gemcitabine 21Radiotherapy 19Prednisolone 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 4 × Radiation × Clear all
NCT00199082 2022-08-19

Newly Diagnosed Mature B-ALL, Burkitt's Lymphoma and Other High-grade Lymphoma in Adults

Goethe University

Phase 4 Completed
650 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Mediastinal Neoplasms, Lymphoma, Large-Cell, Anaplastic, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00686725 2017-06-14

Standard Temodal (Temozolomide) Regimen Versus Standard Regimen Plus Early Postsurgery Temodal for Newly Diagnosed Glioblastoma Multiforme (Study P05572)

Merck Sharp & Dohme LLC

Phase 4 Completed
99 enrolled 15 charts
CNS

Glioblastoma

NCT00911092 2012-01-02

COL06-13

Centre Oscar Lambret

Phase 4 Completed
50 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT01469026 2011-11-10

CUP Project PET/CT

Odense University Hospital

Phase 4 Unknown
220 enrolled

Metastasising Cancer of Unknown Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡